For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.
A team at the Texas A&M Health Institute of Biosciences and Technology has developed an artificial intelligence-designed molecular switch that uses caffeine to rapidly separate engineered proteins inside living cells and trigger cellular responses on demand. The platform, called CODS, short for caffeine-operated dissociation system, could help scientists build safer and more controllable gene and cell therapies.
Have another cup.
To read more, click here.